Sign in
4

Changes in Ownership

Voyager Therapeutics, Inc. Filed Acc 0001104659-24-005244

Chief Scientific Officer sold 1,266 shares at $7.18 ($9,090)

From the SEC's structured data for this filing

Trades in this filing

Carter Todd Alfred · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-17 Sale : show line 1 in the form −1,266 $7.18 $9,090 53,094 D
Open-market sales · 1,266 sh · avg $7.18 · $9,090
Loading xslF345X05/tm243664-1_4seq1.xml…